2019
DOI: 10.1152/ajprenal.00173.2019
|View full text |Cite
|
Sign up to set email alerts
|

Multiple doses of stem cells maintain urethral function in a model of neuromuscular injury resulting in stress urinary incontinence

Abstract: Stress urinary incontinence (SUI) is more prevalent among women who deliver vaginally than women who have had a cesarean section, suggesting that tissue repair after vaginal delivery is insufficient. A single dose of mesenchymal stem cells (MSCs) has been shown to partially restore urethral function in a model of SUI. The aim of the present study was to determine if increasing the number of doses of MSCs improves urethral and pudendal nerve function and anatomy. We hypothesized that increasing the number of MS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
17
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(23 citation statements)
references
References 46 publications
5
17
1
Order By: Relevance
“…Replacing needle injections by water-jet application of cells may reduce the costs for cell production when fewer cells are injected more precisely, avoiding loss of cells by reflux or full penetration [42]. The fewer cells injected by water-jet close to the sphincter muscle may even yield a comparable or even better outcome when compared to multiple injections of more cells by needle in one session, increasing the risk of injury considerably [49,62] or in repeated sections over time, which raises other concerns [63].…”
Section: Discussionmentioning
confidence: 99%
“…Replacing needle injections by water-jet application of cells may reduce the costs for cell production when fewer cells are injected more precisely, avoiding loss of cells by reflux or full penetration [42]. The fewer cells injected by water-jet close to the sphincter muscle may even yield a comparable or even better outcome when compared to multiple injections of more cells by needle in one session, increasing the risk of injury considerably [49,62] or in repeated sections over time, which raises other concerns [63].…”
Section: Discussionmentioning
confidence: 99%
“…Single as well as repeated doses of 2 × 10 6 MSCs 1 h, 7 days, and 14 days after vaginal distension and crushing n. pudendus in rats improved the integrity of the urethra, restoring the composition of its connective tissue and neuromuscular structures. MSC treatment improved elastogenesis, prevented dysfunction of the external urethral sphincter, and restored the n. pudendus morphology [ 7 ].…”
Section: Msc Incontinence Correction In Experimental Modelsmentioning
confidence: 99%
“…Standard therapies often provide symptomatic relief, but do not target against the underlying etiology, and exhibit tremendous patient-to-patient variability of results, limited success, and procedure-related complications. More clinical trials of new treatment methods involving the required number of patients and with evaluation the long-term results of therapeutic methods for the incontinence correction should be encouraged [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…This is critical for translating a promising achievement from the laboratory bench to the patient’s bedside, and later into a specific treatment of clinical daily routine [ 50 ]. Many studies have explored the preclinical and clinical application of stem cells isolated from various origins that have promising results for the treatment of SUI [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 ] and were summoned up as part of the several reviews articles. Hart and colleagues summarized the mainly preclinical published literature on cell therapy models for the regeneration of smooth and striated urethral sphincter muscles, but also the regeneration of nerves and neuromuscular synapses [ 47 ].…”
Section: The Regenerative Approachmentioning
confidence: 99%